This study aimed to validate an in-house script that detects perfusion lesions in dynamic susceptibility contrast magnetic resonance images of acute stroke patients and compare its performance with commercially available software. Perfusion lesions were estimated from time-to-maximum and mean transit time maps of 94 stroke patients using our algorithm, Perfscape/Neuroscape, PMA, and Stroketool. These automatically delineated lesions were volumetrically and spatially compared with those delineated by a trained expert. Our algorithm performs comparably to other programs on the market and overestimates lesion volumes to a lesser extent; however, it is currently limited by its reliance on manual input.
Given the importance of rapidly determining the hemodynamic progression of stroke and the amount of resources that are consumed to this end, there is a need for automated tools to analyze perfusion imaging data. One method of perfusion imaging, known as BOLD delay, is a promising tool for assessing blood flow in stroke without the use of a contrast agent1 but is particularly underserved by current automated tools. We have developed a program to estimate the size and location of potential perfusion lesions in both BOLD delay and dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI). Our algorithm receives a manually delineated diffusion-weighted image (DWI) and a non-delineated, thresholded perfusion image as inputs; searches the vascular territories in which there is a DWI infarct for corresponding perfusion lesions; and outputs high- and medium/low-likelihood perfusion masks representing areas of potential hypoperfusion, based on the size and proximity of perfusion lesions to DWI infarcts (Figure 1). Here, we validated its use with DSC-MRI images and compared its performance on DSC-MRI images with other, commercially available programs.
Perfusion maps of time-to-maximum (Tmax) and mean transit time (MTT) were generated in Perfscape/Neuroscape, PMA, and Stroketool for 94 patients (Mage = 70.9 years; 56 male) with acute ischemic stroke participating in the 3 Tesla Stroke Medical Radiologic Technology for Examining Mismatch in 1000+ (1000Plus; NCT00715533) prospective clinical study.2 Tmax maps were thresholded at 4s and 6s while MTT maps were thresholded at 5s and 6s, based on the literature.3,4 The locations and volumes of hypoperfused tissue were determined in PMA-generated maps using both our program and an expert rater and compared. Next, the volumes of perfusion lesions were calculated using both an automated and manual protocol for the three aforementioned programs,3 and the differences between these two volumes were compared to those for our algorithm. The spatial accuracy of our algorithm relative to the manual rater was evaluated and compared to that of the automated PMA protocol using the Dice similarity index.5
1 Khalil A, Ostwaldt A, Nierhaus T, et al. Relationship Between Changes in the Temporal Dynamics of the Blood-Oxygen-Level-Dependent Signal and Hypoperfusion in Acute Ischemic Stroke. Stroke. 2017;48(4):925-931.
2 Hotter B, Pittl S, Ebinger M, et al. Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset - 1000Plus study. BMC Neurology. 2009;9(1):60.
3 Galinovic I, Ostwaldt T, Soemmer C, et al. Automated vs manual delineations of regions of interest-a comparison in commercially available perfusion MRI software. BMC Medical Imaging. 2012;12(1):16.
4 Olivot J, Mlynash M, Thijs V, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke. 2009;40(2):469-475.
5 Dice, L. Measures of the amount of ecologic association between species. Ecology. 1945;26(3):297-302.
6 Galinovic I, Brunecker P, Ostwaldt A, et al. Fully automated postprocessing carries a risk of substantial overestimation of perfusion deficits in acute stroke magnetic resonance imaging. Cerebrovascular diseases. 2011;31(4):408-413.
7 European Medicines Agency. PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions, including suspension for some marketing authorisations [Press Release]. March 10, 2017. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2017/03/WC500223209.pdf. Accessed September 29, 2018.
8 Copen W, Schaefer P, and Wu O. MR perfusion imaging in acute ischemic stroke. Neuroimaging Clinics. 2011;21(2):259-283.